- Home
- MORN vs AXSM Comparison
MORN vs AXSM Comparison
Compare MORN & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MORN | AXSM |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.0B |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MORN | AXSM |
|---|---|---|
| Price | $204.65 | $185.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 21 |
| Target Price | ★ $322.50 | $190.57 |
| AVG Volume (30 Days) | 383.4K | ★ 873.6K |
| Earning Date | 02-12-2026 | 02-23-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | ★ 16.18 | N/A |
| EPS | ★ 8.80 | N/A |
| Revenue | ★ $2,395,400,000.00 | $561,263,000.00 |
| Revenue This Year | $8.92 | $67.43 |
| Revenue Next Year | $7.55 | $58.11 |
| P/E Ratio | $23.10 | ★ N/A |
| Revenue Growth | 7.76 | ★ 65.83 |
| 52 Week Low | $199.97 | $86.99 |
| 52 Week High | $335.21 | $191.50 |
Technical Indicators
Market Signals| Indicator | MORN | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 64.48 |
| Support Level | $199.97 | $172.05 |
| Resistance Level | $214.74 | $189.95 |
| Average True Range (ATR) | 6.74 | 5.72 |
| MACD | -1.08 | 0.18 |
| Stochastic Oscillator | 24.61 | 77.11 |
Price Performance
Historical ComparisonAbout MORN Morningstar Inc.
Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.